A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life
Microbial Pathogenesis · 2026
DOI: 10.1016/j.micpath.2026.108798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Shangde Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China; State Key Laboratory of National…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Monoclonal, Antibodies, Viral, Ebolavirus. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Agricultural Science and Technology Innovation Fund, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China; State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China.
- College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China.
- State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China.
- College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China. Electronic address: wenyan@just.edu.cn.
- State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China. Electronic address: jky62033@163.com.
- State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China. Electronic address: bioqcx@126.com.
Förderung
- National Natural Science Foundation of China
- Jiangsu Provincial Agricultural Science and Technology Innovation Fund
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Peng, S., Yi, Z., Hu, W., Peng, F., Zhou, X., Feng, J., Wang, N., Wen, Y., Chen, G., & Qiao, C. (2026). A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108798
Vancouver
Peng S, Yi Z, Hu W, Peng F, Zhou X, Feng J, et al. A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108798
BibTeX
@article{Peng2026,
author = {Peng, Shangde and Yi, Zihan and Hu, Wen and Peng, Fenghao and Zhou, Xinyi and Feng, Jiannan and Wang, Na and Wen, Yan and Chen, Guojiang and Qiao, Chunxia},
title = {A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life},
journal = {Microbial Pathogenesis},
year = {2026},
doi = {10.1016/j.micpath.2026.108798}
}
EUVIMED